Chen H, Xu LP, Zhang XH, Wang Y, et al. Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation. Leuk Res 2022;121:106930.
PMID: 36007342